Bruce Peacock - Net Worth and Insider Trading
Bruce Peacock Net Worth
The estimated net worth of Bruce Peacock is at least $6 dollars as of 2024-11-13. Bruce Peacock is the Director of Windtree Therapeutics Inc and owns about 10 shares of Windtree Therapeutics Inc (WINT) stock worth over $6. Details can be seen in Bruce Peacock's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bruce Peacock has not made any transactions after 2020-05-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bruce Peacock
Bruce Peacock Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bruce Peacock owns 8 companies in total, including Ocular Therapeutix Inc (OCUL) , Windtree Therapeutics Inc (WINT) , and Dicerna Pharmaceuticals Inc (DRNA) among others .
Click here to see the complete history of Bruce Peacock’s form 4 insider trades.
Insider Ownership Summary of Bruce Peacock
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
OCUL | Ocular Therapeutix Inc | 2016-06-02 | director |
WINT | Windtree Therapeutics Inc | 2020-05-22 | director |
DRNA | Dicerna Pharmaceuticals Inc | 2017-07-18 | director |
2015-11-19 | director | ||
2014-01-02 | CFO & CBO | ||
2011-10-06 | director | ||
2009-05-28 | director | ||
2008-12-23 | director |
Bruce Peacock Latest Holdings Summary
Bruce Peacock currently owns a total of 1 stock. Bruce Peacock owns 10 shares of Windtree Therapeutics Inc (WINT) as of May 22, 2020, with a value of $6.
Latest Holdings of Bruce Peacock
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
WINT | Windtree Therapeutics Inc | 2020-05-22 | 10 | 0.56 | 6 |
Holding Weightings of Bruce Peacock
Bruce Peacock Form 4 Trading Tracker
According to the SEC Form 4 filings, Bruce Peacock has made a total of 1 transactions in Windtree Therapeutics Inc (WINT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Windtree Therapeutics Inc is the acquisition of 4 shares on May 22, 2020, which cost Bruce Peacock around $25,375.
Insider Trading History of Bruce Peacock
- 1
Bruce Peacock Trading Performance
GuruFocus tracks the stock performance after each of Bruce Peacock's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bruce Peacock is 5.77%. GuruFocus also compares Bruce Peacock's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bruce Peacock within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bruce Peacock's insider trading performs compared to the benchmark.
Performance of Bruce Peacock
Bruce Peacock Ownership Network
Ownership Network List of Bruce Peacock
Ownership Network Relation of Bruce Peacock
Bruce Peacock Owned Company Details
What does Ocular Therapeutix Inc do?
Who are the key executives at Ocular Therapeutix Inc?
Bruce Peacock is the director of Ocular Therapeutix Inc. Other key executives at Ocular Therapeutix Inc include 10 percent owner Summer Road Llc , Chief Business Officer Christopher G White , and Chief Medical Officer Rabia Gurses Ozden .
Ocular Therapeutix Inc (OCUL) Insider Trades Summary
Over the past 18 months, Bruce Peacock made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 31,480 shares made by Antony C. Mattessich , a net sale of 14,942 shares made by Rabia Gurses Ozden , and a net purchase of 2,469,312 shares made by Summer Road Llc .
In summary, during the past 3 months, insiders sold 22,712 shares of Ocular Therapeutix Inc (OCUL) in total and bought 0 shares, with a net sale of 22,712 shares. During the past 18 months, 136,096 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,339,716 shares.
Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocular Therapeutix Inc Insider Transactions
Bruce Peacock Mailing Address
Above is the net worth, insider trading, and ownership report for Bruce Peacock. Currently GuruFocus does not have mailing address information for Bruce Peacock.